Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 2/2016

01-02-2016 | Capsule Commentary

Capsule Commentary on Lafata et al., Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes

Author: Ana M. Palacio, MD, MPH

Published in: Journal of General Internal Medicine | Issue 2/2016

Login to get access

Excerpt

The study by Lafata et al. evaluated whether medication adherence mediated racial disparities in achieving HBA1c, LDL or SBP targets among diabetics.1 The authors found that blacks had poorer medication adherence compared to whites in all three classes of medications, and were less likely to achieve clinical targets. Racial disparities persisted in multivariable models that included medication adherence and treatment intensification. The strengths of the study are the inclusion of patients from multiple sites and the use of objective adherence and outcome data. A limitation was the use of an adherence definition that required having at least two prescriptions filled, since the exclusion of subjects with no or one refill could have introduced bias. …
Literature
1.
Lafata JE, Karter AJ, O’Connor PJ, Morris H, Schmittdiel JA, Ratliff S, Newton KM, Raebel MA, Pathak RD, Thomas A, Butler MG, Reynolds K, Waitzfelder B, Steiner JF. Medication adherence does not explain black-white differences in cardiometabolic risk factor control among insured patients with diabetes. J Gen Intern Med. doi:10.​1007/​s11606-015-3486-0.
2.
Collins SD, Torguson R, Gaglia MA Jr, et al. Does black ethnicity influence the development of stent thrombosis in the drug-eluting stent era? Circulation. 2010;122(11):1085–90.CrossRefPubMed
3.
Kramer MR, Valderrama AL, Casper ML. Decomposing black-white disparities in heart disease mortality in the united states, 1973–2010: An age-period-cohort analysis. Am J Epidemiol. 2015.
4.
Chin MH, Clarke AR, Nocon RS, et al. A roadmap and best practices for organizations to reduce racial and ethnic disparities in health care. J Gen Intern Med. 2012;27(8):992–1000.PubMedCentralCrossRefPubMed
5.
Smedley B, Stith A, Nelson A. Unequal treatment confronting racial and ethnic disparities in health care. Washington DC: National Academy Press; 2002.
Metadata
Title
Capsule Commentary on Lafata et al., Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes
Author
Ana M. Palacio, MD, MPH
Publication date
01-02-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3510-4

Other articles of this Issue 2/2016

Journal of General Internal Medicine 2/2016 Go to the issue

Exercises in Clinical Reasoning

Managing Cognitive Load to Uncover an Unusual Cause of Syncope: Exercises in Clinical Reasoning

Health Policy

The Roles of Cost and Quality Information in Medicare Advantage Plan Enrollment Decisions: an Observational Study

Editorial

Training Future Physicians to Deliver Tobacco Cessation Treatment

Capsule Commentary

Capsule Commentary on Bloom-Feshbach et al., Health Literacy in Transitions of Care: An Innovative Objective Structured Clinical Examination for Fourth Year Medical Students in an Internship Preparation Course

Original Research

Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes

Original Research

Teaching Medical Students to Help Patients Quit Smoking: Outcomes of a 10-School Randomized Controlled Trial
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits